Rabbia Haider1, Likhitha Sudini2, Clara K Chow3, N Wah Cheung3. 1. Westmead Hospital, Sydney, Australia; Sydney Medical School, The University of Sydney, NSW, Australia. Electronic address: rabbia.haider@health.nsw.gov.au. 2. Westmead Hospital, Sydney, Australia. 3. Westmead Hospital, Sydney, Australia; Sydney Medical School, The University of Sydney, NSW, Australia.
Abstract
BACKGROUND: Mobile health is the use of mobile technology in developing healthcare, with the aim of reminding and motivating patients to adopt a healthy lifestyle. We conducted a systematic review assessing the effectiveness of text-messaging interventions on HbA1c in patients with Type 2 diabetes mellitus (T2DM). METHODS: Two authors independently searched MEDLINE, Embase, CINAHL, Cochrane Register of Randomized Control Trials and PsychInfo. The review included randomized control trials with at least 4 weeks follow up, evaluating the effect of text messaging on HbA1c, in patients with T2DM. Trials involving participants with Type 1 diabetes mellitus, pre-diabetes or gestational diabetes, or other forms of telemedicine were excluded. Studies employing bi-directional messaging were excluded. RESULTS: 208 papers were identified as meeting inclusion criteria and their abstracts reviewed. Of these, we examined the full text article of forty-four studies. Eleven randomized controlled trials were included in the final review, with a total of 1710 participants. One study focused on medication adherence only, while the remaining had educational and motivational messages. Five studies showed a significant improvement in HbA1c with the intervention. The remaining studies demonstrated a trend to improvement in HbA1c. Our meta-analysis on 9 of the 11 studies found an overall reduction in HbA1c of 0.38% (-0.53; -0.23, p-value <0.001). CONCLUSION: Lifestyle-focused text messaging is a low cost initiative aimed at motivating patients with T2DM to adhere to a healthy lifestyle. We demonstrate that lifestyle focused text messaging is effective, with a significant improvement in HbA1c in the meta-analysis. Crown
BACKGROUND: Mobile health is the use of mobile technology in developing healthcare, with the aim of reminding and motivating patients to adopt a healthy lifestyle. We conducted a systematic review assessing the effectiveness of text-messaging interventions on HbA1c in patients with Type 2 diabetes mellitus (T2DM). METHODS: Two authors independently searched MEDLINE, Embase, CINAHL, Cochrane Register of Randomized Control Trials and PsychInfo. The review included randomized control trials with at least 4 weeks follow up, evaluating the effect of text messaging on HbA1c, in patients with T2DM. Trials involving participants with Type 1 diabetes mellitus, pre-diabetes or gestational diabetes, or other forms of telemedicine were excluded. Studies employing bi-directional messaging were excluded. RESULTS: 208 papers were identified as meeting inclusion criteria and their abstracts reviewed. Of these, we examined the full text article of forty-four studies. Eleven randomized controlled trials were included in the final review, with a total of 1710 participants. One study focused on medication adherence only, while the remaining had educational and motivational messages. Five studies showed a significant improvement in HbA1c with the intervention. The remaining studies demonstrated a trend to improvement in HbA1c. Our meta-analysis on 9 of the 11 studies found an overall reduction in HbA1c of 0.38% (-0.53; -0.23, p-value <0.001). CONCLUSION: Lifestyle-focused text messaging is a low cost initiative aimed at motivating patients with T2DM to adhere to a healthy lifestyle. We demonstrate that lifestyle focused text messaging is effective, with a significant improvement in HbA1c in the meta-analysis. Crown
Authors: Deborah A Greenwood; Michelle L Litchman; Diana Isaacs; Julia E Blanchette; Jane K Dickinson; Allyson Hughes; Vanessa D Colicchio; Jiancheng Ye; Kirsten Yehl; Andrew Todd; Malinda M Peeples Journal: J Diabetes Sci Technol Date: 2021-08-11
Authors: Yilin Yoshida; Sonal J Patil; Ross C Brownson; Suzanne A Boren; Min Kim; Rosie Dobson; Kayo Waki; Deborah A Greenwood; Astrid Torbjørnsen; Ambady Ramachandran; Christopher Masi; Vivian A Fonseca; Eduardo J Simoes Journal: J Am Med Inform Assoc Date: 2020-06-01 Impact factor: 4.497
Authors: Angelika Sabine Sandholzer-Yilmaz; Eric Sven Kroeber; Wondimu Ayele; T Frese; Eva Johanna Kantelhardt; Susanne Unverzagt Journal: BMJ Open Date: 2022-05-11 Impact factor: 3.006
Authors: Robin Whittemore; Mireya Vilar-Compte; Selene De La Cerda; Roberta Delvy; Sangchoon Jeon; Soraya Burrola-Méndez; Mariana Pardo-Carrillo; Annel Lozano-Marrufo; Rafael Pérez-Escamilla Journal: Curr Dev Nutr Date: 2020-04-14
Authors: Timothy Stevens; Ryan S McGinnis; Blake Hewgill; Rebecca H Choquette; Timothy W Tourville; Jean Harvey; Richard Lachapelle; Bruce D Beynnon; Michael J Toth; Christian Skalka Journal: JMIR Hum Factors Date: 2020-05-11
Authors: Y Kiera Bartlett; Cassandra Kenning; Jack Crosland; Nikki Newhouse; Lisa M Miles; Veronika Williams; Jenny McSharry; Louise Locock; Andrew J Farmer; David P French Journal: BMC Health Serv Res Date: 2021-06-28 Impact factor: 2.655